Will Morton[email protected]Molecular ImagingFES-PET effective for staging breast cancer in phase II trialF-18 fluroestradiol (FES)-PET/CT appears as effective as standard imaging for staging women with estrogen receptor-positive locally advanced breast cancer or evaluating suspected recurrence.July 26, 2024Molecular ImagingPET/MRI rules out tau protein in late-life depressionA PET/MRI study has provided insights into the neurobiology of late-life depression, finding tau protein is not involved in the condition.July 25, 2024Molecular ImagingAuntMinnie.com Molecular Imaging InsiderTau PET is widely used in patients with Alzheimer’s disease, yet may have value in patients with other tauopathies, such as chronic traumatic encephalopathy. Click "Read More" for the details as well as other top molecular imaging news.July 24, 2024Molecular ImagingTau PET identifies grey matter atrophy in retired athletesFlortaucipir PET imaging is able to identify neuropathological brain changes in retired contact sport athletes at risk of neurodegeneration.July 24, 2024MRIHanneman discusses cardiac imaging and environmental sustainabilityCardiac imaging teams should be aware not only of the adverse health effects of climate change but also the downstream environmental ramifications of cardiovascular imaging.July 24, 2024AIGPT-4V generates mixed results in online image quizA recent study shows the GPT-4 Vision multimodal AI model erred when answering medical quiz questions based on clinical images and a text summary.July 23, 2024CTSCCT: AI predicts MACE on coronary CT angiographyAn AI model could help physicians predict whether patients are at risk of death or heart attack based on coronary CT angiography (CCTA) tests.July 19, 2024Radiologic TechnologistSurvey shows RT educators lack AI knowledgeRadiologic technologist educators need AI training and guidance to improve on the teaching and use of AI.July 18, 2024Molecular ImagingPET/MRI superior to PET/CT in cancer patientsFDG-PET/MRI is comparable or superior in diagnostic performance to FDG-PET/CT across a range of cancers and endpoints.July 18, 2024MRIDMI feasible in Alzheimer’s disease patientsDeuterium metabolic imaging (DMI) can reveal impaired brain glucose metabolism in patients with Alzheimer’s disease.July 16, 2024Previous PagePage 22 of 51Next PageTop StoriesDigital X-RayAI predicts death risk from COPDAn AI model for analyzing chest x-rays can identify individuals at risk of death from chronic obstructive pulmonary disease (COPD)Womens ImagingMusic lowers anxiety, pain for women undergoing mammographyMRI5 ways to reduce gadolinium pollutionMinniesMeet the Minnies 2025 finalistsSponsor ContentClinically Meaningful AI Detection of Interval Cancers
![Coronal and axial slice of the average cortical F-18 MK-6240 SUVR [standard uptake value ratio] image for each study population. SUVR images were corrected for partial volume effects and masked with the gray matter mask used for volume of interest delineation. Overall tau accumulation is comparable between the late-life depression (LLD, middle column) and non-depressed cognitively unimpaired comparison (HC, left column) groups, while abnormal tau accumulation, which is most pronounced in the mesial temporal lobe, can be seen in the mild cognitive impairment due to Alzheimer's disease group (right column). Image and caption courtesy of the American Journal of Geriatric Psychiatry.](https://img.auntminnie.com/files/base/smg/all/image/2024/07/Tau_depressed.66a16540ee0a1.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
